Tompkins Financial Corp Novartis Ag Transaction History
Tompkins Financial Corp
- $1.07 Billion
- Q2 2025
A detailed history of Tompkins Financial Corp transactions in Novartis Ag stock. As of the latest transaction made, Tompkins Financial Corp holds 1,810 shares of NVS stock, worth $222,521. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,810
Previous 2,910
37.8%
Holding current value
$222,521
Previous $324,000
32.41%
% of portfolio
0.02%
Previous 0.03%
Shares
19 transactions
Others Institutions Holding NVS
# of Institutions
1,531Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.45 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.28 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1.06 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$867 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$831 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $264B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...